drugset / Trial / NCT00005877

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

NCT00005877

Phase 2 Unknown Astex Pharmaceuticals, Inc.
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have advanced or recurrent colorectal cancer.

Timeline

Start
1999-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject rubitecan Unknown Oral

Indications